← Back to guidelines
Dermatology1 paper

Chronic osteomyelitis of hand

Last edited: 4/15/2026

Overview

Chronic osteomyelitis of the hand involves persistent infection within the bone, leading to inflammation, pain, and potential functional impairment. [Not directly addressed in provided abstracts]

Diagnosis

  • Clinical signs include persistent pain, swelling, and limited range of motion.
  • Imaging studies such as X-rays, MRI, and bone scans are essential for diagnosis and assessing bone involvement.
  • Cultures from affected areas may be necessary to identify the causative organism [Not directly addressed in provided abstracts].
  • Management

  • First-line treatments: Antibiotic therapy tailored to culture and sensitivity results.
  • Adjunctive treatments: Surgical debridement for localized infections or abscesses.
  • Supportive care: Pain management and physical therapy to maintain function.
  • Alitretinoin: Not indicated for chronic osteomyelitis of the hand; primarily used for severe chronic hand dermatitis 1.
  • Special Populations

  • Pregnancy: Limited data; treatment should focus on safe antibiotic options with minimal fetal risk [Not directly addressed in provided abstracts].
  • Pediatrics: Management similar to adults but with greater emphasis on growth and development considerations [Not directly addressed in provided abstracts].
  • Elderly: Increased risk of comorbidities; tailored antibiotic therapy and careful monitoring are crucial [Not directly addressed in provided abstracts].
  • Comorbidities: Presence of diabetes or peripheral vascular disease may complicate healing; close glycemic control and vascular assessment are recommended [Not directly addressed in provided abstracts].
  • Key Recommendations

  • Initiate targeted antibiotic therapy based on culture and sensitivity results to address the specific pathogen (Evidence: Moderate [Not directly addressed in provided abstracts]).
  • Consider surgical intervention for localized infections or when medical management fails (Evidence: Moderate [Not directly addressed in provided abstracts]).
  • Monitor for and manage potential complications, especially in elderly patients or those with comorbidities (Evidence: Expert opinion [Not directly addressed in provided abstracts]).
  • References

    1 Ham K, Maini P, Gooderham MJ. Real-world experience with alitretinoin in a community dermatology practice setting in patients with chronic hand dermatitis. Journal of cutaneous medicine and surgery 2014. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG